TABLE OF CONTENTS
Chapter 1 Prefix
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
2.1 Global Stroke Treatment Market Year-on-Year Growth, 2020 – 2028 (%)
Chapter 3 Market Outline
3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Value Chain Analysis
3.4 Porter’s Five Forces Analysis
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Impact Analysis
3.5.2 Restraints
3.5.2.1 Impact Analysis
3.5.3 Opportunities
Chapter 4 Global Stroke Treatment Market by Type: Market Size and Forecast, 2019 – 2028
4.1 Overview
4.2 Ischemic Stroke
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.3 Hemorrhagic Stroke
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 5 Global Stroke Treatment Market: by Drug Class: Market Size and Forecast, 2019 – 2028
5.1 Overview
5.2 Tissue Plasminogen Activator
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.3 Anticoagulants
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.4 Antiplatelets
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.4.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.5 Anticonvulsants
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.5.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.6 Others
5.6.1 Current Trend and Analysis
5.6.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.6.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 6 Global Stroke Treatment Market by Distribution Channel: Market Size and Forecast, 2019 - 2028
6.1 Overview
6.2 Retail Pharmacies
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
6.3 Hospital Pharmacies
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
6.4 Online Pharmacies
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 7 Global Stroke Treatment Market by Geography: Market Size and Forecast, 2019 - 2028
7.1 Overview
7.1.1 Global Stroke Treatment Market Year-on-Year Growth, by region 2020 – 2028 (%)
7.2 North America
7.2.1 Current Trend and Analysis
7.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.2.3 U.S.
7.2.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.2.3.2 By Type
7.2.3.3 By Drug Class
7.2.3.4 By Distribution Channel
7.2.4 Canada
7.2.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.2.4.2 By Type
7.2.4.3 By Drug Class
7.2.4.4 By Distribution Channel
7.2.5 Mexico
7.2.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.2.5.2 By Type
7.2.5.3 By Drug Class
7.2.5.4 By Distribution Channel
7.3 Europe
7.3.1 Current Trend and Analysis
7.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.3.3 Germany
7.3.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.3.3.2 By Type
7.3.3.3 By Drug Class
7.3.3.4 By Distribution Channel
7.3.4 France
7.3.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.3.4.2 By Type
7.3.4.3 By Drug Class
7.3.4.4 By Distribution Channel
7.3.5 U.K
7.3.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.3.5.2 By Type
7.3.5.3 By Drug Class
7.3.5.4 By Distribution Channel
7.3.6 Spain
7.3.6.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.3.6.2 By Type
7.3.6.3 By Drug Class
7.3.6.4 By Distribution Channel
7.3.7 Others
7.3.7.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.3.7.2 By Type
7.3.7.3 By Drug Class
7.3.7.4 By Distribution Channel
7.4 Asia-Pacific
7.4.1 Current Trend and Analysis
7.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.4.3 China
7.4.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.4.3.2 By Type
7.4.3.3 By Drug Class
7.4.3.4 By Distribution Channel
7.4.4 India
7.4.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.4.4.2 By Type
7.4.4.3 By Drug Class
7.4.4.4 By Distribution Channel
7.4.5 Japan
7.4.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.4.5.2 By Type
7.4.5.3 By Drug Class
7.4.5.4 By Distribution Channel
7.4.6 South Korea
7.4.6.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.4.6.2 By Type
7.4.6.3 By Drug Class
7.4.6.4 By Distribution Channel
7.4.7 Rest of Asia-Pacific
7.4.7.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.4.7.2 By Type
7.4.7.3 By Drug Class
7.4.7.4 By Distribution Channel
7.5 RoW
7.5.1 Current Trend and Analysis
7.5.2 Market Size and Forecast
7.5.3 South America
7.5.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.5.3.2 By Type
7.5.3.3 By Drug Class
7.5.3.4 By Distribution Channel
7.5.4 Middle East
7.5.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.5.4.2 By Type
7.5.4.3 By Drug Class
7.5.4.4 By Distribution Channel
7.5.5 Africa
7.5.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
7.5.5.2 By Type
7.5.5.3 By Drug Class
7.5.5.4 By Distribution Channel
Chapter 8 Company Profiles
8.1 Astrazeneca
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Business Strategies
8.1.4 Financials
8.1.5 Recent Developments
8.2 Genentech
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.2.4 Financials
8.2.5 Recent Developments
8.3 Johnson & Johnson
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 Business Strategies
8.3.4 Financials
8.3.5 Recent Developments
8.4 Biogen Inc.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.4.4 Financials
8.4.5 Recent Developments
8.5 Ingelheim GmbH
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Business Strategies
8.5.4 Financials
8.5.5 Recent Developments
8.6 Daiichi Sankyo Company
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Business Strategies
8.6.4 Financials
8.6.5 Recent Developments
8.7 Sanofi
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Business Strategies
8.7.4 Financials
8.7.5 Recent Developments
8.8 Bristol – Myers Squibb Company
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Business Strategies
8.8.4 Financials
8.8.5 Recent Developments
Payment Options